A  	A  	 DT	O
randomised  	randomised  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
trial  	trial  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
oxytetracycline  	oxytetracycline  	 JJ	B-NP
dose  	dose  	 NN	I-NP
through  	through  	 IN	O
water  	water  	 NN	O
medication  	medication  	 NN	O
of  	of  	 IN	O
nursery  	nursery  	 JJ	O
pigs  	pigs  	 NNS	O
on  	on  	 IN	O
diarrhoea 	diarrhoea 	 NN	O
,  	,  	 ,	O
faecal  	faecal  	 VBZ	O
shedding  	shedding  	 VBG	O
of  	of  	 IN	O
Lawsonia  	Lawsonia  	 NNP	B-NP
intracellularis  	intracellularis  	 NN	I-NP
and  	and  	 CC	O
average  	average  	 JJ	O
daily  	daily  	 JJ	O
weight  	weight  	 NN	B-NP
gain  	gain  	 NN	I-NP
Oral  	Oral  	 NNP	I-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
antimicrobials  	antimicrobials  	 NN	B-NP
is  	is  	 VBZ	O
widely  	widely  	 RB	O
used  	used  	 VBN	O
in  	in  	 IN	O
pig  	pig  	 JJ	O
production  	production  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
control  	control  	 NN	O
of  	of  	 IN	O
gastrointestinal  	gastrointestinal  	 JJ	B-NP
infections 	infections 	 NNS	I-NP
.  	.  	 .	O
Lawsonia  	Lawsonia  	 JJ	B-NP
intracellularis  	intracellularis  	 NNS	I-NP
( 	( 	 -LRB-	O
LI 	LI 	 NNP	B-NP
)  	)  	 -RRB-	O
causes  	causes  	 VBZ	O
enteritis  	enteritis  	 VBN	O
in  	in  	 IN	O
pigs  	pigs  	 NNS	O
older  	older  	 JJR	O
than  	than  	 IN	O
six  	six  	 CD	O
weeks  	weeks  	 NNS	O
of  	of  	 IN	O
age  	age  	 NN	O
and  	and  	 CC	O
is  	is  	 VBZ	O
commonly  	commonly  	 RB	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
antimicrobials 	antimicrobials 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
three  	three  	 CD	O
oral  	oral  	 JJ	B-NP
dosage  	dosage  	 NN	I-NP
regimens  	regimens  	 NNS	I-NP
( 	( 	 -LRB-	O
5 	5 	 CD	O
,  	,  	 ,	O
10  	10  	 CD	O
and  	and  	 CC	O
20mg 	20mg 	 CD	O
/ 	/ 	 CD	O
kg  	kg  	 JJ	B-NP
body  	body  	 NN	I-NP
weight 	weight 	 NN	I-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
oxytetracycline  	oxytetracycline  	 NNS	B-NP
( 	( 	 -LRB-	O
OTC 	OTC 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
drinking  	drinking  	 VBG	B-NP
water  	water  	 NN	I-NP
over  	over  	 IN	O
a  	a  	 DT	O
five-day  	five-day  	 JJ	B-NP
period  	period  	 NN	I-NP
on  	on  	 IN	O
diarrhoea 	diarrhoea 	 NN	O
,  	,  	 ,	O
faecal  	faecal  	 VBZ	O
shedding  	shedding  	 VBG	O
of  	of  	 IN	O
LI  	LI  	 NNP	B-NP
and  	and  	 CC	O
average  	average  	 JJ	B-NP
daily  	daily  	 JJ	I-NP
weight  	weight  	 NN	I-NP
gain  	gain  	 NN	I-NP
( 	( 	 -LRB-	O
ADG 	ADG 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
randomised  	randomised  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
trial  	trial  	 NN	I-NP
was  	was  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
in  	in  	 IN	O
four  	four  	 CD	O
Danish  	Danish  	 JJ	O
pig  	pig  	 NN	O
herds 	herds 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
total 	total 	 NN	O
,  	,  	 ,	O
539  	539  	 CD	O
animals  	animals  	 NNS	O
from  	from  	 IN	O
37  	37  	 CD	O
batches  	batches  	 NNS	O
of  	of  	 IN	O
nursery  	nursery  	 JJ	O
pigs  	pigs  	 NNS	O
were  	were  	 VBD	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
dosage  	dosage  	 JJ	B-NP
regimens  	regimens  	 NN	I-NP
were  	were  	 VBD	O
randomly  	randomly  	 RB	O
allocated  	allocated  	 VBN	O
to  	to  	 TO	O
each  	each  	 DT	O
batch  	batch  	 NN	O
and  	and  	 CC	O
initiated  	initiated  	 VBN	O
at  	at  	 IN	O
presence  	presence  	 NN	O
of  	of  	 IN	O
assumed  	assumed  	 VBN	B-NP
LI-related  	LI-related  	 JJ	I-NP
diarrhoea 	diarrhoea 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
general 	general 	 JJ	O
,  	,  	 ,	O
all  	all  	 DT	O
OTC  	OTC  	 NNP	B-NP
doses  	doses  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
LI  	LI  	 NNP	B-NP
infection  	infection  	 NN	I-NP
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
reduced  	reduced  	 JJ	O
diarrhoea  	diarrhoea  	 NN	O
and  	and  	 CC	O
LI  	LI  	 NNP	B-NP
shedding  	shedding  	 NN	I-NP
after  	after  	 IN	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
Treatment  	Treatment  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
low  	low  	 JJ	O
dose  	dose  	 NN	O
of  	of  	 IN	O
5mg 	5mg 	 FW	B-NP
/ 	/ 	 FW	O
kg  	kg  	 FW	B-NP
OTC  	OTC  	 NNP	I-NP
per  	per  	 IN	O
kg  	kg  	 JJ	B-NP
body  	body  	 NN	I-NP
weight 	weight 	 NN	I-NP
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
tended  	tended  	 VBD	O
to  	to  	 TO	O
cause  	cause  	 VB	O
more  	more  	 RBR	O
watery  	watery  	 JJ	O
faeces  	faeces  	 NN	B-NP
and  	and  	 CC	O
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
higher  	higher  	 JJR	O
odds  	odds  	 NNS	O
of  	of  	 IN	O
pigs  	pigs  	 NNS	O
shedding  	shedding  	 VBG	B-NP
LI  	LI  	 NNP	I-NP
above  	above  	 IN	O
detection  	detection  	 JJ	B-NP
level  	level  	 NN	I-NP
when  	when  	 WRB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
medium  	medium  	 NN	O
and  	and  	 CC	O
high  	high  	 JJ	O
doses  	doses  	 NNS	O
( 	( 	 -LRB-	O
with  	with  	 IN	O
odds  	odds  	 JJ	B-NP
ratios  	ratios  	 NNS	I-NP
of  	of  	 IN	O
5.5  	5.5  	 CD	O
and  	and  	 CC	O
8.4 	8.4 	 CD	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
) 	) 	 -RRB-	O
.  	.  	 .	O
No  	No  	 DT	O
association  	association  	 NN	O
was  	was  	 VBD	O
found  	found  	 VBN	O
between  	between  	 IN	O
the  	the  	 DT	O
dose  	dose  	 NN	O
of  	of  	 IN	O
OTC  	OTC  	 NNP	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
ADG 	ADG 	 NNP	B-NP
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
dose  	dose  	 NN	O
of  	of  	 IN	O
5mg  	5mg  	 NNP	B-NP
OTC  	OTC  	 NNP	I-NP
per  	per  	 IN	O
kg  	kg  	 JJ	B-NP
body  	body  	 NN	I-NP
weight  	weight  	 NN	I-NP
was  	was  	 VBD	O
adequate  	adequate  	 JJ	O
for  	for  	 IN	O
reducing  	reducing  	 VBG	O
the  	the  	 DT	O
high-level  	high-level  	 JJ	O
LI  	LI  	 NNS	B-NP
shedding  	shedding  	 VBG	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
enteropathy 	enteropathy 	 NN	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
a  	a  	 DT	O
dose  	dose  	 NN	O
of  	of  	 IN	O
10mg  	10mg  	 NNP	O
OTC  	OTC  	 NNP	O
per  	per  	 IN	O
kg  	kg  	 JJ	B-NP
body  	body  	 NN	I-NP
weight  	weight  	 NN	I-NP
was  	was  	 VBD	O
necessary  	necessary  	 JJ	O
to  	to  	 TO	O
obtain  	obtain  	 VB	O
a  	a  	 DT	O
maximum  	maximum  	 JJ	O
reduction  	reduction  	 NN	O
in  	in  	 IN	O
LI  	LI  	 NNP	B-NP
shedding 	shedding 	 NN	I-NP
.  	.  	 .	O
